Back
Results - Announcements
Sales decline 32.89% to Rs 3.06 crore
Ishita Drugs & Industries standalone net profit declines 37.93% in the March 2026 quarter
01-Jun-2026, 07:27
Net profit of Ishita Drugs & Industries declined 37.93% to Rs 0.18 crore in the quarter ended March 2026 as against Rs 0.29 crore during the previous quarter ended March 2025. Sales declined 32.89% to Rs 3.06 crore in the quarter ended March 2026 as against Rs 4.56 crore during the previous quarter ended March 2025.
Net profit of Ishita Drugs & Industries declined 37.93% to Rs 0.18 crore in the quarter ended March 2026 as against Rs 0.29 crore during the previous quarter ended March 2025. Sales declined 32.89% to Rs 3.06 crore in the quarter ended March 2026 as against Rs 4.56 crore during the previous quarter ended March 2025.
For the full year,net profit declined 10.34% to Rs 0.78 crore in the year ended March 2026 as against Rs 0.87 crore during the previous year ended March 2025. Sales declined 2.27% to Rs 14.66 crore in the year ended March 2026 as against Rs 15.00 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 3.06 | 4.56 | -33 | 14.66 | 15.00 | -2 |
| OPM % | 3.27 | 6.36 | - | 5.25 | 6.67 | - |
| PBDT | 0.30 | 0.41 | -27 | 1.18 | 1.27 | -7 |
| PBT | 0.28 | 0.38 | -26 | 1.08 | 1.16 | -7 |
| NP | 0.18 | 0.29 | -38 | 0.78 | 0.87 | -10 |
Powered by Capital Market - Live News
